Memorializes Congress to research Acute Myeloid Leukemia treatments.
The bill memorializes Congress to prioritize research, clinical trials, and treatment development for Acute Myeloid Leukemia, a rare and aggressive blood cancer. It urges the National Institutes of Health, the National Cancer Institute, and the Department of Health and Human Services to accelerate efforts, naming these initiatives the "Jonas A. Feeley Act" in honor of a life lost to the disease. The resolution highlights the urgency for improved therapies and the potential to save lives and reduce the burden on families.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.